AFP and neoplasm: In the univariate analysis of the sorafenib group, only the modified ALBI grade (2b/3 vs. 1/2a: HR 0.34; 95% CI 0.17–0.69; p = .0029) was associated with OS, whereas there were no significant differences regarding gender, ECOG‐PS, age, major portal invasion, extrahepatic spread, extrahepatic tumor volume, AFP level, DCP level, and mG8 score (Table 3).